Drug Target - P2Y purinoceptor 12 receptor (P2Y12 receptor)
|
|
US Patent Application: 20090318464
|
|
Patent Owner: AstraZeneca (Sweden)
|
|
 |
|
Drug Types
|
|
Small molecule drugs
|
|
 |
|
Target Diseases
Please refer to the patent or patent application for the complete list of target diseases
|
|
Adult respiratory distress syndrome,
Anti phospholipid syndrome,
Arteritis,
Atheromatous plaque formation,
Coronary angioplasty,
Crohn's disease,
Deep vein thrombosis,
Glomerulonephritis,
Haemolytic uraemic syndrome,
Heparin induced thrombocytopenia,
Microthromboembolism,
Migraine,
Myocardial infarction,
Myocardial infarction,
Organ graft rejection,
Peripheral vascular disease,
Perithrombolysis,
Pre-eclampsia,
Raynaud's phenomenon,
Restenosis,
Sickle cell anemia/disease,
Stenosis,
Thrombocytopenia,
Thrombotic complications of septicaemia,
Thrombotic stroke,
Thrombotic thrombocytopenic purpura,
Transient ischemic attack,
Ulcerative colitis,
Unstable angina,
Vasculitis,
Venoocclusive disease
|
|
 |
|
Assays/Methods Used In This Patent Or Patent Application
Please refer to the patent or patent application for the complete list of methods used and the details of the protocols
|
|
|
|
|
|
Link to USPTO site
|
|
US Patent Application: 20090318464
|
|
|
|
Drug Target - P2Y purinoceptor 12 receptor (P2Y12 receptor)
|
|
US Patent Number: 7,618,949
|
|
Patent Owner: Inspire Pharmaceuticals (USA)
|
|
|
|
Drug Types
|
|
Small molecule drugs
|
|
|
|
Target Diseases
Please refer to the patent or patent application for the complete list of target diseases
|
|
Arterial thrombosis,
Coronary angioplasty,
Hrombotic stroke,
Myocardial infarction,
Peripheral vascular disease,
Unstable angina
|
|
|
|
Assays/Methods Used In This Patent Or Patent Application
Please refer to the patent or patent application for the complete list of methods used and the details of the protocols
|
- Platelet Aggregation Assays
- Calcium Mobilization Assay
- Inhibition of Thrombus Formation in Anesthetized Rats
- Inhibition of Thrombus Formation in Anesthetized Dogs
- Inhibition of Platelet Aggregation by Administration of P2Y12 Antagonists in Dogs
- Prevention of Thromboembolism-Induced Mortality in Mice by the Treatment with P2Y12 Receptor Antagonists
- Reversible Inhibition of Platelet Aggregation by P2Y12 Receptor Antagonists in Mice
- Effect of Different Compounds on ADP-Induced Aggregation
|
|
|
|
|
Link to USPTO site
|
|
US Patent Number: 7,618,949
|
|
|
|
Link to Google Patents
|
|
US Patent: 7,618,949
|
|
|
|
|
Services offered
SciClips Consultancy
|
| Fostering innovation through scientific intelligence |
Sciclips consultancy service team is comprised of highly qualified and experienced scientists who have several years of research experience in
academic and industrial laboratories. We offer following custom services at competitive price:
Scientific and technical areas covered: Drug discovery, Stem cells, Genomics, Proteomics, Biomarkers, Clinical diagnostics,
Companion diagnostics, Molecular diagnostics, Personalized medicine (theranostics), Plant and agricultural biotechnology
Patent search: Custom intellectual property (IP) analysis; Comprehensive patent database search and evaluation |
Custom data analysis and data mining: From patents, research articles, meeting abstracts and web based information. Custom meta analysis. |
Competitive intelligence analysis: Comprehensive analysis of competitive technologies and products; Technology trend prediction; Identification of technology licensing opportunities; Acquisition target identification; Identification of collaborative technology development opportunities. |
Technology development: Identification of potential development opportunities in drug discovery assay development, cell based assay development, recombinant protein expression (in vitro and in vivo) and mass spectrometry/proteomics reagents and tools; Product development strategy. |
Diagnostics and Theranostics technology development: Diagnostic assay development; Diagnostic target identification (molecular or protein or miRNA or metabolomic biomarkers); Prognostic and drug efficacy biomarkers; Theranostics tools, biomarkers and therapeutic drug targets; Identification of emerging technologies and methods. |
Custom database development |
Customized bioinformatics tools: Offered through our partners. |
Proteomics and Drug discovery services (laboratory based): Offered through our partners. |
For more information on our consultancy services please contact us at contact@sciclips.com
or email us using the contact form
|
|
 |
|
|
Receive news updates by email
|
|
|
Search Drug Targets
|
|
|
Search Diseases
|
|
 |
|
|
Keywords:
High Content Screening, Cell Signaling Assays, Methyltransferase Assay, Drug Profiling Service, Pre-Clinical Services, Drug discovery assays, Cell based assays, HTS assays, clinical research services (CRO), GPCR cassays, receptor assays, kinase assays, phosphatase assays, toxicity assays, Reporter Assays,GPCR cell-based assays, Enzyme Inhibitors, screening molecules,Screening Assays,Screening compounds, Small Molecule Screening,Small Molecule Libraries, Raman Spectroscopy,kinase assays, protease assays, caspase assay,apoptosis assays, Receptor Assay, nuclear Receptor Assay,Receptor Binding Assay,Multiplex Assays, calcium assays, Ion Channel Screening, Sodium Channel Screening,HERG channel Assay,genotyping, ATP assay,Glutathione Assay, Genotoxicity assay,Flow Cytometry, Cell Proliferation Assay, Next generation sequencing, contract assay service, High Throughput Screening, Assay development, Drug Discovery Services, Cell based assays, Drug Profiling Service, Compound Profiling, Medicinal chemistry, ion channel assays
|
Drug Targets
